848310-98-5

Basic information

• Product Name: 3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one
• Synonyms: 2-Butanone, 3-(3-bromophenyl)-4-(4-chlorophenyl)-;3-(3-broMophenyl)-4-(4-chlorophenyl)-;3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one
• CAS NO: 848310-98-5
• Molecular Formula: C₁₆H₁₄BrClO
• Molecular Weight: 337.6388
• Product Categories: API intermediates
• Mol File: 848310-98-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 388.045 °C at 760 mmHg
• Flash Point: 188.483 °C
• Appearance: /
• Density: 1.395 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.595
• CAS DataBase Reference: 3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one(848310-98-5)
• EPA Substance Registry System: 3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one(848310-98-5)

Safety Data

• Hazardous Substances Data: 848310-98-5(Hazardous Substances Data)

Usage

General Description

3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one is a chemical compound with the molecular formula C16H14BrClO. It is a ketone derivative with a bromine-substituted phenyl group and a chlorine-substituted phenyl group attached to a butanone backbone. 3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one may be used in various chemical reactions and organic synthesis processes. It is important to handle this compound with caution and follow proper safety measures when working with it due to its potential reactivity and hazard properties.

InChI:InChI=1/C16H14BrClO/c1-11(19)16(13-3-2-4-14(17)10-13)9-12-5-7-15(18)8-6-12/h2-8,10,16H,9H2,1H3

Upstream product

• 676-58-4 methylmagnesium chloride 
• 1204241-05-3 C₁₅H₁₁BrCl₂O 
• 150529-73-0 methyl 2-(3-bromophenyl)acetatee 
• 622-95-7 4-chlorobenzyl bromide 
• 75-16-1 methylmagnesium bromide 

Downstream Products

• 958851-00-8 4-(4-chlorophenyl)-3-(3-cyanophenyl)-2-methylsulfonyloxybutane 
• 958851-01-9 4-(4-chlorophenyl)-3-(3-cyanophenyl)-2-azidobutane 
• 732982-66-0 N-(1S,2S)-[2-(3-cyanophenyl)-3-(4-chlorophenyl)-1-methylpropyl]amine 
• 610791-48-5 N-(1S,2S)-[2-(3-cyanophenyl)-3-(4-chlorophenyl)-1-methylpropyl]amine hydrochloride 
• 958850-94-7 4-(4-chlorophenyl)-3-(3-bromophenyl)-2-butanol 
• 701977-00-6 N-[(1R,2R)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide 
• 701977-09-5 taranabant 
• 610791-48-5 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]amine hydrochloride 

Relevant articles and documents

SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present in

RADIOLABELED CANNABINOID-1 RECEPTOR MODULATORS

The present invention relates to particular radiolabeled Cannabinoid-1 (CB1) receptor modulators, and methods of using these modulators for labeling and diagnostic imaging of Cannabinoid-1 receptors in mammals, particularly humans. In addition, intermediates useful for the synthesis of the radiolabeled Cannabinoid-1 receptor modulators are also disclosed, as well as the processes for synthesizing the radiolabeled Cannabinoid-1 receptor modulators. Still further, formulations of the radiolabeled Cannabinoid-1 receptor compounds are described.